RegisterLogin

Bleomycin A2

CAT: 0804-HY-146646Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-146646Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Bleomycin A2, an antitumor antibiotic promoting DNA-degradation, is an aspartate/asparagine-β-hydroxylase (AspH) inhibitor with an IC50 of 1.47 μM[1].
CAS Number
[41432-97-7]
UNSPSC
12352005
Target
Antibiotic
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/bleomycin-a2.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C)N[C@H](C(N[C@H](C)[C@@H](O)[C@H](C)C(N[C@]([C@H](O)C)([H])C(NCCC2=NC(C3=NC(C(NCCC[S+](C)C)=O)=CS3)=CS2)=O)=O)=O)[C@H](C4=CN=CN4)O[C@H]5[C@H]([C@H]([C@@H]([C@@H](O5)CO)O)O)O[C@]6([H])[C@H]([C@H]([C@@H]([C@H](O6)CO)O)OC(N)=O)O.O=S([O-])(O)=O
Molecular Formula
C55H85N17O25S4
Molecular Weight
1512.62
References & Citations
[1]Lennart Brewitz, et al. Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase. Bioorg Med Chem. 2020 Oct 15;28 (20) :115675.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Glycopeptide

Related Products

CatalogName
HY-108345Bleomycin
HY-17565-01Bleomycin (sulfate)
HY-W749297Bleomycin B2
HY-N10470-01Bleomycin A5
HY-17565A-01Bleomycin (hydrochloride)
HY-N10469-01Bleomycin B4
HY-125918Bleomycin A5 (hydrochloride)
HY-17565RBleomycin (sulfate) (Standard)
HY-K1053-01Bleomycin D1 Selection Antibiotic, Sterile
HY-P76170-01BLMH/Bleomycin Hydrolase, Mouse (His)

Alternative Products

CatalogName
B053-50MGBleomycin
M25042A-01Bleomycin hydrochloride
JH561962Bleomycin sulfate
RM-B120515-01Bleomycin B4
443036Bleomycin Acid
TN10074-01Bleomycin B2
A14378-10Bleomycin 10mg
A14378-100Bleomycin 100mg
T65016-01Bleomycin A2

Popular Products